Trial to Evaluate the Efficacy, Safety and Tolerability of BPaMZ in Drug-Sensitive (DS-TB) Adult Patients and Drug-Resistant (DR-TB) Adult Patients

NCT03338621 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

455

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis, Pulmonary
Tuberculosis, Multidrug-Resistant
Tuberculosis, MDR
Tuberculosis
Drug-Resistant Tuberculosis

Interventions

DRUG: Pretomanid
DRUG: Bedaquiline
DRUG: Moxifloxacin
DRUG: Pyrazinamide
DRUG: HRZE
DRUG: HR

Sponsor

Global Alliance for TB Drug Development